Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPGAP: Nab-paclitaxel + Gemcitabine in Advanced Pancreatic Cancer
NCT02135822Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in pancreatic ductal adenocarcinoma (PDAC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02135822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135822.